In the present study, we investigated the effects of oral dosing of atrazine (2-chloro-4-ethylamino-6-isopropylamino-s-triazine) to peripubertal male rats (50 and 200 mg/kg body weight daily from postnatal days 23-50) on ex vivo Leydig cell steroidogenesis. Leydig cells from treated rats were characterised by significant decline in mRNA transcripts of several genes responsible for steroidogenesis: luteinizing hormone receptor (LHR), scavenger receptor-B1, steroidogenic acute regulatory protein, translocator protein, steroidogenic factor-1, phosphodiesterase 4B, 3b2hydroxysteroid dehydrogenase (HSD), CYP17A1, and 17bHSD. In the presence of human chorion gonadotropin, the dose-dependent decrease in extracellular cAMP level and accordingly strong inhibition of androgenesis were obtained. The transcription of LHR gene in Leydig cells of atrazine-treated rats was downregulated in a dose-dependent manner, which could be the reason for reduction in cAMP level and expression of cAMPdependent genes. To clarify the activity of the steroidogenic enzymes responsible for androgenesis, purified Leydig cells were challenged with different steroid substrates (22OH-cholesterol, pregnenolone, progesterone, and D 4 -androstenedione), and the obtained results indicated inhibition of androgen production in Leydig cells isolated from atrazine-treated animals in the presence of all those substrates. However, when Leydig cells were challenged with 22OH-cholesterol, the progesterone level in the incubation medium was unchanged, indicating that decrease in cholesterol transport and/or CYP17A1 and 17bHSD activity are most probably responsible for inhibition of androgen production after the addition of different substrates. Our results demonstrated that in vivo exposure to atrazine affects Leydig cell steroidogenesis via the inhibition of steroidogenesis gene expression, which is accompanied by decreased androgenesis.
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Atrazine (2-chloro-4-ethylamino-6-isopropylamino-s-triazine) is a well-known herbicide that inhibits selectively the photosynthesis in broadleaf and grasses on crops. It is one of the most commonly used herbicides in Serbia (Gasic et al., 2002) , and together with its microbial degradation products, it was detected in groundwater in the Vojvodina Province (Gasic et al., 2002; Pucarevic et al., 2002) . Despite the existence of new chemical compounds, atrazine is still being used in large quantities worldwide, and it is one of the two most widely used agricultural pesticides in United States (Barr et al., 2007) . It has been suggested that the exposure to atrazine or its degradates appears more pervasive than previously believed. However, more data are needed to confirm this observation (Barr et al., 2007) . In the EU, there is a uniform limit of 0.1 ppb for the residue of any pesticide in drinking and groundwater, and therefore, based on the inability to keep water contamination below this level, European regulators announced the ban of atrazine use (Sass and Colangelo, 2006) .
Atrazine metabolites are relatively persistent in soil/sediment, with mean aerobic and anaerobic soil half-lives ranging from 58-547 days, and aerobic aquatic half-life about twofold higher (reviewed by: Solomon et al., 2008) . However, the halflife is much shorter in rats. About 93% of atrazine is excreted in rat urine and feces in the first 72 h after oral dosing (Timchalk et al., 1990) . Despite its relatively short half-life in adult rats (< 1 day), many laboratories showed that atrazine administration affected adversely the endocrine system and reproductive tissue development in rats (reviewed by : Cooper et al., 2007; Solomon and Schettler, 2000; Solomon et al., 2008) . Long-term dietary exposure to 400 ppm atrazine (~22.5 mg/kg) caused an early onset of mammary tumors in SpragueDawley rats, and the occurrence of tumors was mediated by atrazine-induced premature reproductive aging (Eldridge et al., 1994 (Eldridge et al., , 1999a . It has been shown that atrazine-suppressed conversion of testosterone (T) to dihydrotestosterone (DHT) in hypothalamus, anterior pituitary, and prostate (Babic-Gojmerac et al., 1989; Kniewald et al., 1995 Kniewald et al., , 2000 , reduced DHT binding to androgen receptor in the prostate (Kniewald et al., 1995) , reduced pituitary, prostate and seminal vesicle weights (Kniewald et al., 2000; Stoker et al., 2000a; Trentacoste et al., 2001) , and is also associated with a reduced semen quality and fertility in men living in agricultural areas (Swan, 2006) . Atrazine has been reported to delay signs of puberty in both females and males, when administered via oral gavage according to the ''pubertal male assay,'' described in the Endocrine Disruptor Screening Program Tier I Screen assays (Stoker et al., 2000b) . It has been demonstrated that atrazine exposure from postnatal day (pnd) 21 until 53 caused a significant decrease in serum and testicular testosterone levels when administered at doses of 100-200 mg/kg body weight (Stoker et al., 2000a) . The study of Trentacoste et al. (2001) suggested that serum luteinizing hormone (LH) and testosterone-reducing ability of atrazine is only observed at doses at or above 100 mg/kg per day and that reduction is secondary to weight loss. On the other hand, Friedmann (2002) demonstrated that atrazine applied by gavage in the dose of 50 mg/kg body weight/day reduced significantly the serum and intratesticular testosterone levels, both acutely (from pnd 46 to 48) and chronically (from pnd 22 to 48). A recent study (Rosenberg et al., 2008) demonstrated that atrazine exposure during Sprague-Dawley rat gestation caused significant decrease in serum testosterone concentrations in the 50-100 mg/ kg/day groups at pnd 60 in comparison to controls. Besides that, the mechanisms by which atrazine exposure elicits changes in peripubertal Leydig cell steroidogenesis remains unexplained.
Risk assessment for population to exogenous sources of endocrine disruptors depends partly on identification of mechanisms of action of those chemicals. Therefore, the present study was designed to identify the possible site(s) of atrazineinduced lesion(s) affecting Leydig cell androgen biosynthesis. The following outputs were evaluated in Leydig cells obtained from peripubertal rats treated by gavage with atrazine from pnd 23 to 51, and from the corresponding control: production of testosterone and progesterone in the basal and in stimulated conditions (in the presence of human chorionic gonadotropin (hCG), or steroidogenic substrates), the level of extracellular cAMP, and expression of steroidogenesis-related genes. Transcripts for luteinizing hormone receptor (LHR), scavenger receptor B1 (SR-B1), steroidogenic factor-1 (SF-1), steroidogenic acute regulatory protein (StAR), translocator protein (TSPO), phospodiesterase 4B (PDE4B) which participate in the cAMP-dependent control of steroidogenesis, as well as 3b-hydroxysteroid dehydrogenase (HSD), CYP17A1, and 17bHSD were determined in hCG-stimulated Leydig cells. -androstenedione, testosterone, and trypan blue were obtained from Sigma (Steinheim, Germany), whereas human CG (hCG; Pregnyl, 3000 IU/ mg) was obtained from Organon (West Orange, NJ). All other reagents were of analytical grade.
MATERIAL AND METHODS

Chemicals
Animals and in vivo treatments. All experiments were performed with peripubertal male Wistar rats raised in animal facility at the Department of Biology and Ecology under controlled environmental conditions (temperature 22 ± 2°C and 14-h light/10-h dark) with food and water ad libitum. Groups of rats were treated by gavage (po) with two relatively high doses of atrazine (50 and 200 mg/kg body weight/day from pnd 23 to 50) selected on the bases of already shown consisted inhibitory effect on testosterone production in peripubertal male rats (Friedmann, 2002; Stoker et al., 2000a; Trentacoste et al., 2001) . Our aim was to further investigate possible mechanism(s) of atrazine action on Leydig cell steroidogenesis. Atrazine was dissolved in olive oil to desired concentrations. The control group of rats received olive oil. Animals were sacrificed 24 h after the last po-administration. All experiments were approved by the Local Animal Ethical Committee of the University of Novi Sad and were conducted in accordance with the principles and procedures of the National Institutes of Health Guide for Care and Use of Laboratory Animals.
Leydig cell purification and incubation procedure. Isolation and purification of Leydig cells has been done according to Leckie et al. (1998) with some modifications as previously described (Andric et al., 2008) . The proportion of Leydig cells present in the culture was determined by staining for 3bHSD activity (Payne et al., 1980) and was typically more than 95%. In each experiment, the purified Leydig cells obtained individually from four to eight rats were pooled and each pool/group was cultured in three to eight replicates. The cells were allowed 3h to attach to 96-well plate (50,000 cells/0.2 ml/well) and then stimulated for 2 h with M199 containing different concentrations of hCG or different steroid substrates: 22-OH cholesterol, pregnenolone, progesterone and D 4 -androstenedione. Additionally, in each experiment, purified Leydig cells were plated in 50-mm Petri dishes (2.5 3 10 6 cells/2-ml culture medium/dish) and we analyzed not only the androgens and progesterone levels in the medium, but also the RNA transcript levels by real time PCR. The cells were cultured in M199-0.1% BSA supplemented with saturated dose (10 ng/ml) of hCG. When purified Leydig cells were stimulated with different concentrations of 22OH-cholesterol (1 and 50lM) for 2 h, the cells were plated in 50-mm Petri dishes (1 3 10 6 cells/2 ml of culture medium/dish) and progesterone and androgen levels were measured in the medium. After the treatment, cell-free media were collected and stored at À80°C prior to measurement of cAMP, androgen and progesterone levels, whereas cell lysates were used for real time PCR analysis.
Hormone and cAMP assays. Androgen and progesterone levels in the incubation medium were estimated by RIA. Each experiment was run in a single assay. The precision of androgen assay was 6 pg/tube; intra-and interassay coefficients of variation were 5.8 and 7.5%, respectively. Because the anti-testosterone serum used in our assay has a high cross-reactivity with dihydrotestosterone, assay values are referred to as testosterone þ dihydrotestosterone levels (T þ DHT). Progesterone measurements were also done in one assay (sensitivity 6 pg/tube; intra-assay coefficient of variation 6-8%). Serum LH level was determined by RIA according to the supplier's protocol, and samples from all experiments were run in one assay. The minimum detectable concentration has been assayed at 0.14 ng/ml. The amounts of cAMP secreted into the culture medium, were measured by the cAMP EIA Kit which typically displays an IC 50 of approximately 0.5 pmol/ml and a detection limit of 0.1 pmol/ml (at 80% B/B 0 ) for acetylated cAMP samples.
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Reverse transcription polymerase chain reaction. Total RNAs from purified rat Leydig cells, were isolated using RNAqueous 4PCR kit and following the protocol recommended by the supplier. Concentrations of RNA, measured by absorbance at 260 nm, and purity estimated by the 260/280-nm absorbance ratio, were determined spectrophotometrically (Evolution 100, Thermo Electron Corporation, Cambridge, UK). To eliminate residual genomic DNA, RNA samples were treated with 1 ll of DNase-1 (2 IU/ll in a 60 ll of RNA samples). Following DNase-1 treatment, up to 2 lg of the total RNA from each sample were reverse transcribed into cDNA in a 20 ll reaction mixture containing random primers and MultiScribe reverse transcriptase (Applied Biosystems) according to the supplier's instructions. Reverse transcription was estimated at 25°C for 10 min, 37°C for 120 min and followed by 85°C for 5 s in the Veriti Thermal Cycler (Applied Biosystems). Real time PCR was performed with the 7900HT Fast Real-Time PCR system (Applied Biosystems). The SYBR Green PCR Master Mix reagent kits were used according to the supplier's instructions for quantification of gene expression. Rat specific primers were designed for the relevant genes: LHR, SR-B1, StAR, TSPO, SF-1, PDE4B, 3bHSD, CYP17A1, and 17bHSD. The housekeeping gene b-actin was used as an endogenous control. Primers were design by using software Primer Express 3.0 (Applied Biosystems) and full genes sequences from National Center for Biotechnology Information Entrez Nucleotide Database (www.ncbi.nlm.nih.gov/sites/entrez).
Cycling conditions, determined in ABI Prism 7900HT SDS (Sequence Detection System) protocol, were as follows: 50°C for 2 min, 95°C for 10 min followed by 40 cycles of 94°C for 15 s and 60°C for 1 min, in the presence of 200nM of specific forward and reverse primers and 5 ll of product from reverse transcription reaction. Amplification efficiencies were determined to be 100% for both the gene of target and b-actin (data not shown). After real time PCR, a melting curve analysis was conducted to demonstrate the specificity of the PCR product, which was displayed by a single peak for all investigated genes (data not shown). The calculation of the relative expression levels of each target was conducted based on the cycle threshold (C t ) method. The C t for each sample was calculated using the SDS Relative Quantification Manager Software (Applied Biosystem) with an automatic fluorescence threshold (DR n ) setting. The relative expression ratio (R) of a target gene is expressed in a sample versus a control in comparison to b-actin gene and calculated based on the following equation:
Statistical analysis. The results shown are mean ± SEM values of individual replicates from three to eight independent experiments (four to eight rats per group per experiment). The data were analyzed by a one-way ANOVA, followed by Duncan's multiple-range post hoc test, and p < 0.05 was considered as a significant difference.
RESULTS
Serum Hormone Levels
The serum androgen (T þ DHT) and LH levels were measured 24 h after the last po-administration of atrazine. Although it appears that there is the reduction in serum LH levels in 200 mg/kg treated-rats, the values were not statistically different from the control (Fig. 1) . On the other hand, serum T þ DHT concentration was significantly lower in rats treated with a higher atrazine dose (Fig. 1) .
Impact of Atrazine on Different Steps in Leydig Cell Steroidogenesis
In order to estimate possible effect of atrazine on steroidogenic pathway in Leydig cells, the ex vivo basal and hCGsupported androgen, progesterone and cAMP production by purified Leydig cells was investigated. In Leydig cells obtained from atrazine-treated rats, the basal (Fig. 2 , right side of the panel A, and panel C) and hCG-stimulated androgen production was strongly inhibited in a dose-dependent manner (Fig. 2 , right side of the panels B and C). Otherwise, progesterone production by Leydig cells obtained from atrazine-treated rats remained unaltered in basal (Fig. 2 , left side of the panel A) conditions, whereas in the presence of saturated dose of hCG, there is a tendency of dose-dependent decrease of progesterone level which became statistically significant in Leydig cells obtained from 200 mg-atrazine/kg/day group (Fig. 2, left side of the panel B) . In parallel with inhibited androgen production, atrazine induced dose-dependent decrease in extracellular cAMP levels, in both basal and hCG-stimulated conditions (Fig. 3) .
To clarify the status of the steroidogenic enzymes responsible for androgenesis, purified Leydig cells were challenged with different steroid substrates: 22OH-cholesterol (Fig. 4A, and Figs. 5A and 5B), pregnenolone (Fig. 4B) , progesterone ( Fig. 4C) and D 4 -androstenedione (Fig. 4D) . The obtained results indicated the inhibition of T þ DHT production in Leydig cells isolated from atrazine-treated animals in the presence of all substrates. The strongest inhibition was expressed in the presence of 22OH-cholesterol, and the lowest in the presence of D 4 -androstenedione as a substrate. In addition, progesterone levels were measured after the incubation of Leydig cells with the medium containing steroid substrate 22OH-cholesterol (1 and 50lM). The results showed that progesterone production was not altered, when 22OH-cholesterol, a steroid substrate able to enter mitochondria without a carrier, was added in the culture media (Figs. 5A and 5B, left side panels).
Expression of Genes Responsible for Steroidogenesis in
Leydig Cells Affected by Atrazine Treatment The effects of atrazine exposure on mRNA transcription of genes involved in LH action, cholesterol transport and steroidogenesis in male rats were determined (Fig. 6) .
FIG. 1. Serum androgens and LH levels after po-administration of atrazine. Groups of animals were treated by gavage (po) with atrazine, for 28 days and sacrificed 24 h after the last treatment. Trunk blood was collected from both control and atrazine-treated animals, and serum T þ DHT and LH levels were determined by RIA. Columns represent the mean ± SEM values of 26 replicates from 4 independent experiments, and in each experiment, the serum was obtained from five to eight animals per group. Statistical significance is represented by letters: a ¼ p < 0.001 between atrazine-treated rats and corresponding controls, and d ¼ p < 0.05 between the two atrazinetreatments.
ATRAZINE INHIBITS STEROIDOGENESIS GENES IN LC
Compared with the controls, the expression of the gene for LHR was reduced significantly by 45 and 72% in the 50 and 200 mg atrazine/kg/day groups, respectively (Fig. 6A) . The same pattern was detected in the expression of the gene for plasma cholesterol transporting to steroidogenic tissues, that is, transcript levels for SR-B1 were reduced significantly by 23 and 64% in the 50 and 200 mg atrazine/kg/day groups, respectively ( Fig. 6A) . The results showed that expression of genes involved in cholesterol transport to the inner mitochondrial membrane was reduced in atrazine-treated rats; both doses were effective in decreasing the expression of gene for StAR by 47 and 66% in the 50 and 200 mg atrazine/kg/day groups, respectively ( Fig. 6A) , whereas in the case of TSPO, the transcript level was reduced by 74% (Fig. 6B ) only in the 200 mg/kg/day group. Also, the expression of gene for SF-1 was reduced significantly by 47 and 66% in the 50 and 200 mg atrazine/kg/day groups (Fig.  6B) . We also analyzed the expression of gene for PDE4B, which is a cAMP-specific form of PDE4, and is expressed in Sertoli and Leydig cells. The result indicated that atrazine treatment reduced the transcripts level for PDE4B at both doses by 51 and 59%, respectively (Fig. 6B) . Compared with the control, the expression of gene for 3bHSD, the enzyme that catalyses the conversion of pregnenolone to progesterone, was not affected by atrazine treatment (Fig. 6C) . However, the transcript levels for other steroidogenic enzymes CYP 17A1 and 17bHSD were reduced in a dosedependent manner; CYP17A1 by 53 and 81% and 17bHSD by 54 and 68%, in the 50 and 200 mg atrazine/kg/day groups, respectively ( Fig. 6C) .
Effects of Atrazine on Androgen-Dependent Organ and Body Weights
As shown in Table 1 , atrazine caused reduction in the androgen-dependent organ weights. Treatment with atrazine at both doses reduced testis and seminal vesicles weights significantly. Ventral and dorsal prostate weights were also decreased in rats treated with a higher dose of atrazine. In addition, the results showed an increase in adrenal gland weights after atrazine treatment at both doses. The examination of body weights of atrazine-treated rats demonstrated that rats
FIG. 2. Effect of atrazine on ex vivo basal (A) and hCG-supported (B)
androgen and progesterone production in purified Leydig cells (LC). Panel C represents androgen production in the function of hCG concentration (0-20 ng/ ml of incubation medium). Purified Leydig cells, obtained from the control or atrazine-treated (50 mg/kg, 200 mg/kg) rats, were plated in 50-mm Petri dishes (2.5 x10 6 LC/dish/2 ml) without (A) or with hCG (10 ng/ml) (B) in the medium or incubated in 96-well plate: 50,000 LC/well/0.2 ml without or with different doses of hCG in the medium (C), for 2 h. Androgen and progesterone levels were determined by RIA. Columns in panels A and B represent mean ± SEM values of 12-24 replicates from 4 independent experiments (three to eight replicates per experiment: in each experiment LC were obtained from four to five animal per group). In (C), the dots represent mean ± SEM values of 24 replicates (eight replicates per experiment) from three independent experiments and in each experiment LC were obtained from five to eight animals per group. Statistical significance is represented by letters: a ¼ p < 0.001, b ¼ p < 0.01, c ¼ p < 0.05 between atrazine-treated rats and corresponding controls, and d ¼ p < 0.05 between the two atrazine-treatments. which had received atrazine at a higher dose, showed significant reduction in body weights during and 24 h after the treatment (Fig. 7) .
DISCUSSION
The focus of this study was to define the possible mechanism(s) of inhibition of Leydig cell steroidogenesis in peripubertal rats after in vivo exposure to atrazine. In spite of relatively numerous data related to atrazine-induced inhibition of androgenesis (Friedmann, 2002; Rosenberg et al., 2008; Stoker et al., 2000a; Trentacoste et al., 2001) , no relevant data signifying possible mechanism(s) of atrazine action have been published.
Steroidogenesis in Leydig cells is predominantly mediated by interaction of LH with LHR through the involvement of multiple signaling pathways including cAMP-dependent regulatory events which lead to, by far, the most robust increase in steroid synthesis and which are well defined (Manna et al., 2006 (Manna et al., , 2007 . Although acute response of steroidogenesis is initiated by mobilization and delivery of cholesterol from the outer to the inner mitochondrial membrane where it is metabolized to pregnenolone by the cytochrome P450 cholesterol side chain cleavage enzyme (P450scc), the chronic response involves the increased transcription/translation of steroidogenic enzymes genes (Stocco et al., 2005) . Our results demonstrated that the Leydig cells of atrazine-treated rats were characterised by strongly reduced expression of several genes responsible for steroidogenesis, dose-dependent decreased cAMP level, and strong inhibition of androgenesis, both in the presence of hCG, or corresponding steroid substrates. The transcription of the gene for LHR in Leydig cells of atrazinetreated rats was down-regulated in a dose-dependent manner, which could be the reason for reduction in the cAMP level. On the other hand, it is known that cAMP/PKA pathway upregulates the expression of genes for StAR (Rao et al., 2003; Stocco et al., 2005) , SR-B1 (Azhar and Reaven, 2002; Rao et al., 2003) , and SF-1 (Lehmann et al., 2005; Urs et al., 2007) , and our results on down-regulation of expression of those genes, in the environment of low cAMP levels in atrazine-treated rats, confirmed such relations. Thus, it can be predicted that decreased levels of cAMP could lead to low expression of those genes. Furthermore, it is known that SF-1 controls the expression of several genes involved in steroidogenesis, including genes for CYP17A1 (Li et al., 2007; Sewer and Jagarlapudi, 2009 ), StAR, CYP11A1 (Suzawa and Ingraham, 2008) , and SR-B1 (Azhar and Reaven, 2002) . Our results indicated dose-dependent inhibition of expression of all those genes in rats exposed to atrazine, except for CYP11A1 
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the expression of which was not measured in our study. However, when Leydig cells of rats exposed to atrazine were challenged with 22OH-cholesterol, the progesterone level in the medium was unchanged, whereas T þ DHT level was strongly inhibited. According to the results of unaltered progesterone level after addition of 22OH-cholesterol, it could be speculated that in our study, the expressions of genes for CYP11A1 and 3bHSD were not affected, and the obtained results on unaltered expression of gene for 3bHSD partly confirmed such speculation. Furthermore, according to the results of Payne and Youngblood (1995) , the expressions of 3bHSDI and CYP11A1 in mouse Leydig cells do not depend on cAMP levels. However, according to other authors, SF-1 is involved in the control of CYP11A1 gene expression (Lehmann et al., 2005; Suzawa and Ingraham, 2008) .
In addition to the StAR protein, which plays a critical role in the movement of cholesterol across the mitochondrial membrane, the mitochondrial high affinity cholesterol binding protein TSPO works in a co-ordinated manner with StAR to transfer cholesterol into mitochondria. It has been demonstrated that TSPO functions as a channel specific for cholesterol. Therefore, the regulation of expression of this TSPO channel protein will control the amount of cholesterol available for testosterone synthesis and consequently testicular function. Trophic hormones stimulate steroid production acutely by acting on the rate-determining step of steroidogenesis, and transport of cholesterol from intracellular sources to the inner mitochondrial membrane (reviewed by Papadopoulos et al., 2007) . Our results showed that atrazine induced dosedependent decrease of transcript levels for StAR, whereas in the case of TSPO transcripts, only higher dose was effective.
Atrazine was also effective in decreasing transcripts for CYP17A1 and 17bHSD. De novo synthesis of CYP17A1 stops in the absence of cAMP, and expression of this enzyme depends on SF-1 (Payne, 2007) . The decreased conversion of different steroidogenic substrates to T þ DHT in atrazinetreated rats in our study, could be attributed to the decreased enzyme activity in that part of steroidogenic pathways, that is, with down-regulated expression of CYP17A1 and 17bHSD.
We also tested the effect of atrazine on cAMP concentration, which is regulated either at the level of synthesis by alterations 6 LC/ dish), and incubated in the medium with hCG (10 ng/ml), for 2 h. Total RNA was isolated from Leydig cells obtained from the control and atrazine-treated rats, after 2 h of incubation in the presence of 10 ng hCG (as in Fig. 2B ). RealTime PCR reactions were performed by SYBR Green technology in the presence of specific primers. Calculation of the relative expression levels of each target was conducted based on the cycle threshold (C t ) method; b-actin was used as endogenous control. Columns represent mean ± SEM values of three independent experiments. Statistical significance is represented by letters: a ¼ p < 0.001, b ¼ p < 0.01, c ¼ p < 0.05 between atrazine-treated rats and corresponding controls, and d ¼ p < 0.05 between the two treatments. in adenylyl cyclase activity/synthesis or at the level of degradation by cAMP-specific PDE. The testicular PDE4A and B are cAMP-specific PDE4 and are expressed in a cellspecific manner. The PDE4A isoform is predominantly localized in germ cells of post meiotic stages of differentiation, whereas PDE4B is localized mainly in Sertoli and Leydig cells (Farooqui et al., 2001) . In this study, we did not follow the destiny of adenylyl cyclase, but because transcripts for LHR were dose-dependently inhibited, it could be supposed that the effect of adenylyl cyclase was also reduced resulting in a low cAMP level. On the other hand, our results demonstrated that atrazine treatment reduced the transcript levels for PDE4B. If that reduction is followed by a lower PDE4B protein level in Leydig cells, it could be speculated that hydrolysis of cAMP was also lowered, but not to such a degree to overcome the reduced activity of adenylyl cyclase. Results on lower cAMP levels in treated rats suggested that atrazine acts upstream from the cAMP step. However, the results of our study have shown that atrazine inhibits not only the basal and hCG-stimulated androgen production, but also substrate-supported androgen production. It is already discussed that transcripts for CYP17A1 and 17bHSD were also reduced. Therefore, it could be suggested that possible atrazine-induced lesions affecting Leydig cell androgenesis are located not only upstream from the cAMP step, but that downstream steps are also affected, that is, the transport of cholesterol to mitochondria and conversion of progesterone to testosterone.
The results also showed that oral administration of atrazine produced significant reduction in serum T þ DHT level when applied in dose of 200 mg/kg/day, and significant reduction in the weights of androgen-dependent organs at both doses. At the same time, the application of atrazine did not change significantly the serum LH levels, but the results demonstrated the tendency to reduction in rats treated with a higher dose of 200 mg/kg/day. In those rats, significant reduction of body weights during and at the end of treatment was observed. It should be mentioned that Trentacoste et al. (2001) suggested that testosterone-reducing ability of atrazine is secondary to weight loss. However, our results showed that in spite of absence of weight loss in 50 mg/kg/day treated animals, markedly decreased in vitro basal and hCG-stimulated Leydig cell androgenesis was certainly evident. The results of Stoker et al. (2002) also suggested that reduction in body weight is not the prerequisite for identifying the effects of atrazine or its metabolites on reproductive development. We also observed significant increase in relative weights of adrenal gland in both atrazine-treated groups, compared with controls. Such result obviously requests explanation, but the results obtained in this study allow only highly speculative suggestion that atrazine might inhibit steroidogenesis in the adrenal cortex as well as in Leydig cells, and that adrenocortical insufficiency could result in adrenal hypertrophy (Harvey and Everett, 2003) . Moreover, the effect which we observed might be caused by disruption of the adrenal gland-pituitary-gonadal feedback mechanisms at a time when the adrenal glands are still developing as suggested by Grote et al. (2004) in case of tributyltin and triphenyltin which also induced adrenal weight increase in parallel with decreased serum testosterone level in peripubertal rats after 30-day oral drug treatment.
Results obtained in this study represent novel findings demonstrating the effect of atrazine on expression of genes for steroidogenic enzymes and regulatory proteins involved in the control of testicular steroidogenesis. Our results clearly suggest 24.75 ± 2.39 c Note. Numbers represent ± SEM of two independent experiments (eight animals per experiment). bw ¼ body weight. Statistical significance is represented by letters: a ¼ p < 0.05, b ¼ p < 0.01, c ¼ p < 0.001 between atrazine-treated rats and corresponding controls, and d ¼ p < 0.05 between the two treatments.
that in vivo atrazine treatment might have the ability to interfere with testicular steroidogenesis by decreasing the LHR and SR-B1 levels, transport of cholesterol to the mitochondria, as well as conversion of progesterone to testosterone. Results showing inhibition of substrate-supported androgen production, together with reduced levels of transcripts for CYP17A1 and 17bHSD strongly support assumption that atrazine-induced lesions affecting Leydig cell androgenesis are located not only upstream from the cAMP step, but also downstream influencing the transport of cholesterol to mitochondria and conversion of progesterone to testosterone. However, it should be mentioned that the results on gene expression need to be confirmed on the protein level. These results, in spite of the fact that the doses used in this study are rather unlikely to appear in the environment, represent novel finding on atrazine toxicity.
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